295 related articles for article (PubMed ID: 26553540)
1. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
Costantino S; Paneni F; Lüscher TF; Cosentino F
Eur Heart J; 2016 Feb; 37(6):572-6. PubMed ID: 26553540
[TBL] [Abstract][Full Text] [Related]
2. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
Yildirim SS; Akman D; Catalucci D; Turan B
Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66
Costantino S; Paneni F; Mitchell K; Mohammed SA; Hussain S; Gkolfos C; Berrino L; Volpe M; Schwarzwald C; Lüscher TF; Cosentino F
Int J Cardiol; 2018 Oct; 268():179-186. PubMed ID: 30047409
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
[TBL] [Abstract][Full Text] [Related]
6. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
[TBL] [Abstract][Full Text] [Related]
7. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
8. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.
Diao X; Shen E; Wang X; Hu B
Mol Med Rep; 2011; 4(4):633-40. PubMed ID: 21584493
[TBL] [Abstract][Full Text] [Related]
9. The MicroRNAs in the Pathogenesis of Metabolic Memory.
Zhong X; Liao Y; Chen L; Liu G; Feng Y; Zeng T; Zhang J
Endocrinology; 2015 Sep; 156(9):3157-68. PubMed ID: 26083874
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
[TBL] [Abstract][Full Text] [Related]
11. miR-483-3p regulates hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice.
Qiao Y; Zhao Y; Liu Y; Ma N; Wang C; Zou J; Liu Z; Zhou Z; Han D; He J; Sun Q; Liu Y; Xu C; Du Z; Huang H
Biochem Biophys Res Commun; 2016 Sep; 477(4):541-547. PubMed ID: 27346130
[TBL] [Abstract][Full Text] [Related]
12. Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase.
Nandi SS; Zheng H; Sharma NM; Shahshahan HR; Patel KP; Mishra PK
Diabetes; 2016 Oct; 65(10):3075-90. PubMed ID: 27411382
[TBL] [Abstract][Full Text] [Related]
13. Altered microRNA expression profiles in retinas with diabetic retinopathy.
Wu JH; Gao Y; Ren AJ; Zhao SH; Zhong M; Peng YJ; Shen W; Jing M; Liu L
Ophthalmic Res; 2012; 47(4):195-201. PubMed ID: 22156553
[TBL] [Abstract][Full Text] [Related]
14. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control.
Santovito D; De Nardis V; Marcantonio P; Mandolini C; Paganelli C; Vitale E; Buttitta F; Bucci M; Mezzetti A; Consoli A; Cipollone F
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1681-5. PubMed ID: 24937531
[TBL] [Abstract][Full Text] [Related]
15. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 regulates disabled-2 and Wnt3a expression in cardiomyocytes under hyperglycaemia.
Wang BW; Fang WJ; Shyu KG
Eur J Clin Invest; 2018 Jan; 48(1):. PubMed ID: 29178342
[TBL] [Abstract][Full Text] [Related]
17. Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways.
Lew JK; Pearson JT; Schwenke DO; Katare R
Cardiovasc Diabetol; 2017 Jan; 16(1):10. PubMed ID: 28086863
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
Bernardo BC; Yildiz GS; Kiriazis H; Harmawan CA; Tai CMK; Ritchie RH; McMullen JR
Cells; 2022 Oct; 11(19):. PubMed ID: 36231079
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
20. miRNA-1 regulates endothelin-1 in diabetes.
Feng B; Cao Y; Chen S; Ruiz M; Chakrabarti S
Life Sci; 2014 Mar; 98(1):18-23. PubMed ID: 24394957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
